Global Potential Analysis of Human DNA Vaccines Market is expected to account for $3,762 million in 2020 and reach $9,337 million by 2030, by growing at a CAGR of 9.5% during the period, 2020 - 2030.
Report Code : A01978 | Pages : 120 | Category : Life Sciences
The global api intermediate market was valued at $139.4 billion in 2022, and is projected to reach $285 billion by 2032, growing at a CAGR of 7.4% from 2023 to 2032.
Report Code : A02308 | Pages : 390 | Category : Life Sciences
The global multiple sclerosis therapies market size was valued at $22.99 million in 2018, and is projected to reach $28.00 million by 2026, registering a CAGR of 2.5% ...
Report Code : A01119 | Pages : 151 | Category : Life Sciences
The global leukemia therapeutics market size was valued at $7,818.63 million in 2021 and is estimated to reach $14,162.48 million by 2031, exhibiting a CAGR of 6.1% from 2022 to 2031.
Report Code : A01128 | Pages : 392 | Category : Life Sciences
The lymphoma therapeutics market was valued at $15,691.45 million in 2022 and is projected to reach $35,207.45 million by 2032, registering a CAGR of 8.4% from 2023 to 2032.
Report Code : A01129 | Pages : 481 | Category : Life Sciences
The global cancer vaccines market was valued at $4,188 million in 2019, and is projected to reach $7,303 million by 2027, registering a CAGR of 12.6% from 2020 to 2027.
Report Code : A01134 | Pages : 284 | Category : Life Sciences
Antibody Drug Conjugates Market are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. ADC™s are designed to eliminate cancer cells only without harming the ...
Report Code : A01148 | Pages : 152 | Category : Life Sciences
The global pregabalin market was valued at $1.6 billion in 2022, and is projected to reach $2.2 billion by 2032, growing at a CAGR of 3% from 2023 to 2032.
Report Code : A02320 | Pages : 289 | Category : Life Sciences
The global prostate cancer treatment market size was valued at $6,887 million in 2018, and is projected to reach $9,904 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Report Code : A02321 | Pages : 188 | Category : Life Sciences
The global enteric softgel capsules market was valued at $2.3 billion in 2022, and is projected to reach $3.5 billion by 2032, growing at a CAGR of 4% from 2023 to 2032.
Report Code : A02601 | Pages : 250 | Category : Life Sciences
